| Product Code: ETC7548378 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Multidrug Resistant Bacteria Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Multidrug Resistant Bacteria Market Revenues & Volume, 2021 & 2031F |
3.3 India Multidrug Resistant Bacteria Market - Industry Life Cycle |
3.4 India Multidrug Resistant Bacteria Market - Porter's Five Forces |
3.5 India Multidrug Resistant Bacteria Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 India Multidrug Resistant Bacteria Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.7 India Multidrug Resistant Bacteria Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 India Multidrug Resistant Bacteria Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 India Multidrug Resistant Bacteria Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant bacteria in India |
4.2.2 Growing awareness about the importance of infection control measures |
4.2.3 Rising healthcare expenditure and investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Lack of effective antibiotic stewardship programs |
4.3.2 Limited access to advanced diagnostic tools for detecting multidrug-resistant bacteria |
4.3.3 High cost associated with the treatment of multidrug-resistant infections |
5 India Multidrug Resistant Bacteria Market Trends |
6 India Multidrug Resistant Bacteria Market, By Types |
6.1 India Multidrug Resistant Bacteria Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 India Multidrug Resistant Bacteria Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 India Multidrug Resistant Bacteria Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 India Multidrug Resistant Bacteria Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 India Multidrug Resistant Bacteria Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 India Multidrug Resistant Bacteria Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.1.7 India Multidrug Resistant Bacteria Market Revenues & Volume, By Acute Bacterial Skin and Skin Structure Infections, 2021- 2031F |
6.1.8 India Multidrug Resistant Bacteria Market Revenues & Volume, By Hospital Acquired Bacterial Pneumonia, 2021- 2031F |
6.2 India Multidrug Resistant Bacteria Market, By Pathogen |
6.2.1 Overview and Analysis |
6.2.2 India Multidrug Resistant Bacteria Market Revenues & Volume, By E. coli, 2021- 2031F |
6.2.3 India Multidrug Resistant Bacteria Market Revenues & Volume, By P. Aeruginosa, 2021- 2031F |
6.2.4 India Multidrug Resistant Bacteria Market Revenues & Volume, By K. Pneumoniae, 2021- 2031F |
6.2.5 India Multidrug Resistant Bacteria Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Multidrug Resistant Bacteria Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 India Multidrug Resistant Bacteria Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.3.3 India Multidrug Resistant Bacteria Market Revenues & Volume, By Lipoglycopeptides, 2021- 2031F |
6.3.4 India Multidrug Resistant Bacteria Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.3.5 India Multidrug Resistant Bacteria Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.3.6 India Multidrug Resistant Bacteria Market Revenues & Volume, By Combination Therapies, 2021- 2031F |
6.3.7 India Multidrug Resistant Bacteria Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Multidrug Resistant Bacteria Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 India Multidrug Resistant Bacteria Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Multidrug Resistant Bacteria Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 India Multidrug Resistant Bacteria Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 India Multidrug Resistant Bacteria Market Revenues & Volume, By Others, 2021- 2031F |
7 India Multidrug Resistant Bacteria Market Import-Export Trade Statistics |
7.1 India Multidrug Resistant Bacteria Market Export to Major Countries |
7.2 India Multidrug Resistant Bacteria Market Imports from Major Countries |
8 India Multidrug Resistant Bacteria Market Key Performance Indicators |
8.1 Percentage increase in the adoption of infection control practices in healthcare facilities |
8.2 Number of research studies and publications on multidrug-resistant bacteria in India |
8.3 Rate of development and implementation of antibiotic stewardship programs in healthcare settings |
9 India Multidrug Resistant Bacteria Market - Opportunity Assessment |
9.1 India Multidrug Resistant Bacteria Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 India Multidrug Resistant Bacteria Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.3 India Multidrug Resistant Bacteria Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 India Multidrug Resistant Bacteria Market Opportunity Assessment, By End users, 2021 & 2031F |
10 India Multidrug Resistant Bacteria Market - Competitive Landscape |
10.1 India Multidrug Resistant Bacteria Market Revenue Share, By Companies, 2024 |
10.2 India Multidrug Resistant Bacteria Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here